Clinical Trials Arena, a leading flagship GlobalData publication has a headline article today about the BioSecure Act and its potential effects on the drug development space in the US and internationally. Ali Pashazadeh, Treehill Partners CEO, provides a healthy and much needed dose of realism to the issue.
Read on here: